Abbott

What if we told you that, in a survey of 41 people living with Parkinson's disease who had undergone a remote audio-visual DBS tele-programming session, 98% reported that telehealth improved their access to healthcare services?

More than 50 million Americans live with chronic pain.1 SCS and DRG therapy can help address chronic pain by interrupting the pain signals traveling along the spinal cord or the dorsal root ganglia, a cluster of nerves along the spine, before they can reach the brain.

What happens when the medical caretakers are ill-equipped to care for your personal caretakers? The answer — so far — for the cardiovascular care of women and people of color has not been encouraging.

The traditional healthcare model has become more agile and connected seemingly overnight, just as technology — like Abbott’s COVID-19 rapid tests and FreeStyle Libre system — is empowering people to take ownership of their health like never before.

Abbott was recognized as an ESG industry leader in the S&P Global Sustainability Yearbook, with a focus on advancing access and equity in health.

Announced by JUST Capital and its media partner CNBC, the JUST 100 list recognizes companies that outperform on the issues that matter most to the American public – including meeting the needs of employees, customers, communities and the environment.

Across the U.S. and around the world, low-income communities and communities of color are facing health crises at alarming rates. Chronic diseases like heart disease and diabetes are responsible for more than 71% of deaths globally, and 88% of deaths in the U.S. As with other health challenges, the impact of these diseases disproportionately impact underserved communities, resulting in massive health disparities that are passed on to future generations.

Abbott is addressing a key challenge to health equity by putting a greater focus on breaking down the barriers to clinical trial participation for under-represented groups